A defective herpes simplex virus vector system for gene delivery into the brain: Comparison with alternative gene delivery systems and usefulness for gene therapy

Clinical Neuroscience

Volumn 3, Issue 5, 1995, Pages 262-267

  Neve, Rachael L ^a,b   Geller, Alfred I ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

Alzheimer's disease; gene; herpes simplex virus; neurotransmitter

Indexed keywords

VIRUS VECTOR;

ALZHEIMER DISEASE; BRAIN FUNCTION; EPILEPSY; GENE TARGETING; GENETIC RECOMBINATION; HERPES SIMPLEX VIRUS 1; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; BRAIN; CELLS, CULTURED; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HUMANS; NEURONS; PLASMIDS;

EID: 0029548403     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Akli S, Caillaud C, Vigne E, StratfordPerricaudet LD, Poenaru L, Perricaudet M, Kahn A, Peschanski MR (1993): Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet 3:224-228.
2. Bahr BA, Neve RL, Sharp J, Geller AI, Lynch G (1994): Rapid and stable gene expression in hippocampal slice cultures from a defective HSV-1 vector. Mol Brain Res 26:277-285.
3. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A (1993): Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet 3:229-234.
4. hNGFR defines high-affinity NGF binding. J Neurosci 13:941-951.
5. Bergold PJ, Casaccia-Bonefil P, Xiu-Liu Z, Federoff HJ (1993) Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor. Proc Natl Acad Sci USA 90:6156-6169.
6. Benowitz LI, Rodriguez W, Paskevich P, Mufson E, Schenk D, Neve RL (1989): The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects. Exp Neurol 106:237-250.
7. Byrnes AP, MacLaren RD, Charlton HM (1996): Immunological instability of persistent adenovirus vectors in the brain: Peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. ] Neurosci 16:3045-3055.
8. Caillaud C, Akli S, Vigne E, Koulakoff A, Perricaudet M, Poenaru L, Kahn A, Berwald-Netter Y (1993): Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells. Eur J Neurosci 5:1287-1291.
9. Castro-Alamancos MA, Torres-Aleman I (1994): Learning of the conditioned eye-blink response is impaired by an antisense insulin-like growth factor I oligonudeotide. Proc Natl Acad Sci USA 91:10203-10207.
10. Chiocca EA, Choi BB, Cai W, DeLuca NA, Schaffer PA, DiFiglia M, Breakefield XO, Martuza RL (1990): Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biol 2:739-746.
11. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM (1992): In vivo gene transfer with retroviral vectorproducer cells for treatment of experimental brain tumors. Science 256:15501552.
12. Davidson BL, Alien ED, Kozarski KF, Wilson JM, Roessler BJ (1993): A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet 3:219-223.
13. Dobson AT, Margolis TP, Sedarati F, Stevens JG, Feldman LT (1990): A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons. Neuron 5:353-360.
14. During MJ, Naegele JR, O'Malley KL, Geller AI (1994): Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266:1399-1403.
15. Federoff HJ, Geschwind MS, Geller AI, Kessler JA (1992): Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc Natl Acad Sci USA 89:16361640.
16. Fink DJ, Sternberg LR, Weber PC, Mata M, Coins WF, Glorioso JC (1992): In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Hum Gene Ther 3:11-19.
17. Fisher L], Schinstine M, Salvaterra P, Dekker AJ, Thal L, Gage FH (1993): In vivo production and release of acetylcholine from primary fibroblasts genetically modified to express choline acetyltransferase. J Neurochem 61:1323-1332.
18. Frim DM, Uhler TA, Galpern WR, Béai MF, Breakefield XO, Isacson O (1994): Transplanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc Natl Acad Sci USA 91:5104-5108.
19. Gage FH, Coates PW, Palmer TD, Kühn HG, Fisher LJ, Suhonen JO, Peterson DA, Suhr ST, Ray J (1995): Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci USA 92:1187911883.
20. Geller AI, Keyomarsi K, Bryan J, Pardee AB (1990): An efficient deletion mutant packaging system for defective herpes simplex virus vectors: Potential applications to human gene therapy and neuronal physiology. Proc Natl Acad Sci USA 90:7603-7607.
21. Geller AI, During MF, Neve RL (1991): Molecular analysis of neuronal physiology by. gene transfer into neurons with herpes simplex virus vectors. Trends Neurosci 14:428-432.
22. Geller AI, During MJ, Haycock JW, Freese A, Neve RL (1993): Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector. Proc Natl Acad Sci USA 90:7603-7607.
23. Geller AI, During MJ, Neve RL (1994): A defective herpes simplex virus vector system for genetic intervention in the adult brain: Applications to gene therapy and neuronal physiology. In Flanagan TR, Emerich DF, Winn S (eds): Providing Therapeutic Access to the Brain: Alternate Approaches (Methods in Neuroscience, Vol 21). San Diego, ÇA: Academic Press, pp 443-461.
24. Geller A, Song S, Lim F, Lang P, Yu L, Want Y, Fraefel C (1995): A helper virus-free packaging system for HSV-1 plasmid vectors that supports efficient gene transfer in the rat brain. Soc Neurosci Abstr 1995:820.
25. Hashimoto M, Aruga J, Hosoya Y, Kanegae Y, Saito I, Mikoshiba K (1996): A neural cell-type-specific expression system using recombinant adenovirus vectors. Hum Gene Ther 7:149-158.
26. Huang Q, Vonsattel J-P, Schaffer PA, Martuza RL, Breakefield XO, DeFiglia M (1992): Introduction of a foreign gene (Escherichia coli lacZ) into rat neostriatal neurons using herpes simplex virus mutants: A light and electron microscopic study. Exp Neurol 115:303-316.
27. Hunter AJ, Leslie RA, Gloger IS, Lawrence M (1995): Probing the function of novel genes in the nervous system: Is antisense the answer? Trends Neurosci 18:320-323.
28. Ho DY, Mocarski ES, Sapolsky RM (1993) Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc Natl. Acad Sci USA 90:3655-3659.
29. Ikari H, Zhang L, Chernak JM, Mastrangeli A, Kato S, Kuo H, Crystal RG, Ingram DK, Roth GS (1995): Adenovirus-mediated gene transfer of dopamine D2 receptor cDNA into rat striatum. Mol Brain Res 34:315-320.
30. Isacson I (1995): Behavioral effects and gene delivery in a rat model of Parkinson's disease. Science 269:856-857.
31. Jiao S, Acsadi G, Jani A, Feigner PL, Wolff JA (1992): Persistence of plasmid DNA and expression in rat brain cells in vivo. ExpNeurol 115:400-413.
32. Johnson PA, Miyanohara A, Levine F, Cahill T, Friedmann T (1992a): Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J Virol 66:2952-2965.
33. Johnson PA, Yoshida K, Gage FH, Friedmann T (Ï992b): Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector. Mol Brain Res 12:95102.
34. Kammesheidt A, Boyce FM, Spanoyannis AF, Cummings BJ, Ortegon M, Cotman CW, Vaught JL, Neve KL (1992): Amyloid deposition and neuronal pathology in transgenic mice expressing the carboxyterminal fragment of the Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci USA 89:10857-10861.
35. Kang UJ, Fisher LJ, JoK TH, O'Malley KL, Gage FH .(1993): Regulation of dopamine production by genetically modified primary fibroblasts. J Neurosci 13:5203-5211.
36. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DVV, O'Malley KL, During MJ (1994): Long-term gene expression and phenotypic correction using adenoassociated virus vectors in the mammalian brain. Nature Genet 8:148-154.
37. Kato K, Yoneda y, Okada Y, Kiyama H, Shiosaka S (1994): Gene transfer and the expression of a foreign gene in vivo in postmitotic neurons of the adult rat brain using the hemagglutinating virus of the Japan-liposome method. Mol Brain Res 25:359-363.
38. Lawrence MS, Ho DY, Dash R, Sapolsky RM (1995): Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss. Proc Natl Acad Sci USA 92:7247-7251.
39. Lawrence MS, Ho DY, Sun GH, Steinberg GK, Sapolsky RM (1996): Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci 15:486-496.
40. Le Gai La Salle G, Robert JJ, Berrard S, Ridoux V, Stratford-Perricaudet LD, Perricaudet M, Mallet J (1993): An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988-990.
41. Lim F, Hartley D, Starr P, Lang P, Song S, Yu L, Wang Y, Geller AI (1996): Generation of high-liter defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. Biotechniques 20:460-470.
42. Lowenstein PR, Fournel S, Bain D, Tomasec P, Clissold PM, Castro MG, Epstein AL (1995): Simultaneous detection of amplicon and HSV-1 helper encoded proteins reveals that neurons and astrocytoma cells do express amplicon-borne transgenes in the absence of synthesis of virus immediate early proteins. Mol Brain Res 30:169-175.
43. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996): In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
44. Neve RL, Kozlowski MR (1994): Role of the carboxyterminus of the Alzheimer amyloid protein precursor in Alzheimer's disease neurodegeneration. In Giacobini E, Becker R (eds): Alzheimer Disease: Therapeutic Strategies. Boston: Birkhauser, pp 375-379.
45. Neve RL, Boyce FM, McPhie DL, OsterGranite ML (1996): Transgenic mice expressing APP-C100 in the brain. Neurobiol Aging 17:191-203.
46. Ogawa S, Olazâbal UE, Parhar IS, Pfaff DW (1994): Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproductive behavior and progesterone receptor immunoreactivity in female rat. J Neurosci 14:1766-1774.
47. Ono T, Fujino Y, Tsuchiya T, Tsuda M (1990): Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells. Neurosci Lett 117:259-263.
48. Plata-Salamân CR, Wilson C, Sonti G, Borkoski]F,Ffrench-MullenJMH(1995): Antisense oligodeoxynucleotides to G-
49. oA subunit. Mol Brain Res 33:72-78.
50. Pollio G, Xue P, Zanisi M, Nicolin A, Maggi A (1993): Antisense oligonucleotide blocks progesterone-induced lordosis behavior in ovariectomized rats. Mol Brain Res 19:135-139.
51. Renfranz PJ, Cunningham MG, McKay RDG (1991): Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain. Cell 66:713-729.
52. Sabaté O, Horellou P, Vigne E, Coliin P, Perricaudet M, Buc-Caron M-H, Mallet J (1995): Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses. Nature Genet 9:256-260.
53. Snyder EY, Deitcher DL, Walsh C, ArnoldAldea S, Hartwieg EA, Cepko CL (1992): Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68:33-51.
54. Snyder EY, Taylor RM, Wolfe JH (1995): Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374:367370.
55. Tripathy SK, Black HB, Goldvvasser E, Leiden JM (1996): Immune responses to transgene-encoded proteins limit the stability of gene expression after injec-tion of replication-defective adenovirus vectors. Nature Med 2:545-550.
56. Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M (1993a): Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259:528-531.
57. Wahlestedt C, Golanov E, Yamamoto S, Yee F, Ericson H, Yoo H, Inturrisi CE, Reis DJ (1993b): Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 363:260-263.
58. Wilkemeyer MF, Smith KL, Zarei MM, Benke TA, Swann JW, Angelides KJ, Eisensmith RC (1996): Adenovirusmediated gene transfer into dissociated and expiant cultures of rat hippocampal neurons. J Neurosci Res 43:161-174.
59. Wojcik BE, Nothias F, Lazar M, Jouin H, Nicolas J-F, Peschanski M (1993): Catecholaminergic neurons result from intracerebral implantation of embryonal carcinoma cells. Proc Natl Acad Sci USA 90:1305-1309.
60. Wolfe JH, Deshmane SL, Fraser NW (1992): Herpesvirus vector gene transfer and expression of β-glucuronidase in the central nervous system of MPS VII mice. Nature Genet 1:379-384.
61. Xu H, Federoff H, Maragos J, Parada LF, Kessler JA (1994) Viral transduction of trkA into cultured nodose and spinal motor neurons conveys NGF responsiveness. Dev Biol 163:152-161.